NCT02099734 Germ Cell Tumor and Testicular Tumor DNA Registry
| NCT ID | NCT02099734 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Memorial Sloan Kettering Cancer Center |
| Condition | Germ Cell Tumor |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2014-01 |
| Primary Completion | 2028-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2014-01 with a primary completion date of 2028-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is being done to create a registry to help us learn more about germ cell tumors (GCT) and other testicular tumors. The registry will include people with these tumors and also relatives and unrelated people without these tumors. This study will help us learn more about the prevention, diagnosis, treatment and outcome of these tumors. Studying relatives of patients and people unrelated to patients with GCT and other testicular tumors will help us understand why some people get these tumors and why some people don't.
Eligibility Criteria
Inclusion Criteria: Case Cohort * Must be ≥ 18 years of age AND * Must be an English-speaker AND * Must have a diagnosis or suspicion of germ cell tumor and/or a testicular mass Family Member Cohort * Must be ≥ 18 years of age AND * Must be an English-speaker AND * Must be a blood relative of the proband. Family members of probands are eligible. These individuals need not have a diagnosis of GCT-TT, as they will be used for segregation analysis of suspected variants found in the proband. Control Cohort * Must be ≥ 18 years of age AND * Must be an English-speaker AND * Must not have a personal history of cancer, with the exception of non-melanoma skin cancer, AND * Must not have a family history of germ cell tumor or testicular tumor AND * Must not be a blood relative of controls enrolled in this study Exclusion Criteria:
Contact & Investigator
Darren Feldman, MD
📞 646-422-4491
Darren Feldman, MD
PRINCIPAL INVESTIGATOR
Memorial Sloan Kettering Cancer Center
Frequently Asked Questions
Who can join the NCT02099734 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Germ Cell Tumor. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02099734 currently recruiting?
Yes, NCT02099734 is actively recruiting participants. Visit ClinicalTrials.gov or contact Memorial Sloan Kettering Cancer Center to inquire about joining.
Where is the NCT02099734 trial being conducted?
This trial is being conducted at Basking Ridge, United States, Middletown, United States, Montvale, United States, Cold Spring Harbor, United States and 4 additional locations.
Who is sponsoring the NCT02099734 clinical trial?
NCT02099734 is sponsored by Memorial Sloan Kettering Cancer Center. The principal investigator is Darren Feldman, MD at Memorial Sloan Kettering Cancer Center. The trial plans to enroll 1,000 participants.